dc.contributor.author | Erelel, Mustafa | |
dc.contributor.author | Yakar, Aysun | |
dc.contributor.author | Yakar, Fatih | |
dc.contributor.author | Buyukpinarbasili, Nur | |
dc.date.accessioned | 2021-03-05T13:19:26Z | |
dc.date.available | 2021-03-05T13:19:26Z | |
dc.identifier.citation | Yakar F., Yakar A., Buyukpinarbasili N., Erelel M., "Does Every Necrotizing Granulomatous Inflammation Identified by NSCLC Resection Material Require Treatment?", MEDICAL SCIENCE MONITOR, cilt.22, ss.1218-1222, 2016 | |
dc.identifier.issn | 1643-3750 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_b1aaa5c0-ff1c-4417-8b0a-2aa35df68121 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/118361 | |
dc.identifier.uri | https://doi.org/10.12659/msm.897638 | |
dc.description.abstract | Background: Lung cancer and tuberculosis (TB) are two major public health problems. They can coexist or appear sequentially. In patients with TB, lung cancer risk is increased. However, vice versa is not crystal clear. In this study, we aimed to determine the development of TB in patients with resectabled non-small cell lung cancer (NSCLC) in a 2-year postoperative follow-up period. | |
dc.language.iso | eng | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Tıbbi Ekoloji ve Hidroklimatoloji | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Klinik Tıp | |
dc.subject | TIP, ARAŞTIRMA VE DENEYSEL | |
dc.title | Does Every Necrotizing Granulomatous Inflammation Identified by NSCLC Resection Material Require Treatment? | |
dc.type | Makale | |
dc.relation.journal | MEDICAL SCIENCE MONITOR | |
dc.contributor.department | Bezmiâlem Vakıf Üniversitesi , , | |
dc.identifier.volume | 22 | |
dc.identifier.startpage | 1218 | |
dc.identifier.endpage | 1222 | |
dc.contributor.firstauthorID | 231640 | |